Oct 09, 2018
Astellas Details Progress and Commitment to Patients and the Community in the Company's Americas 2017 Corporate Social Responsibility Report Card
Sep 25, 2018
Working Mother Magazine names Astellas among 100 best companies in the US across all industries
Sep 24, 2018
Astellas Farma Brasil named one of the best companies to work for in Brazil
Sep 18, 2018
Astellas Promotes Geoff Towle to Vice President of Oncology Marketing at Astellas US
Sep 13, 2018
More than 800 Astellas Employees Volunteer for 16 Community Organizations as Part of Ninth Annual Changing Tomorrow Day
Aug 23, 2018
Astellas Promotes Rodrigo Fernandez to Vice President, Latin America
May 02, 2018
Astellas Included in Forbes Best Midsize Employers List for Fourth Year
Mar 15, 2018
Astellas Names Percival Barretto-Ko President, Americas Operations
Mar 13, 2018
Astellas Announces Key Leadership Changes in Legal, Human Resources
Dec 04, 2017
Astellas Appoints João Carlos de Britto as General Manager of Astellas Farma Brasil
Nov 10, 2017
Astellas Named a Best Place to Work for Lesbian, Gay, Bisexual, and Transgender Equality for Fourth Consecutive Year
Oct 31, 2017
Astellas Appoints Nate Crisel to Vice President, Real World Informatics & Analytics
Sep 26, 2017
Working Mother Magazine names Astellas among 100 best companies in the US across all industries
Aug 31, 2017
Astellas to Present New Data for Enzalutamide and IMAB362 at 2017 European Society of Medical Oncology (ESMO) Annual Meeting
Jul 13, 2017
Astellas Head of Medical Affairs Americas Shontelle Dodson Joins National Pharmaceutical Council Board of Directors
Jul 12, 2017
Astellas Announces Leadership Changes in US Commercial Organization
Jun 26, 2017
Astellas Announces Leadership Promotions in Marketing Strategy and US Commercial Organizations
Jun 22, 2017
The Lancet Oncology Publishes Anti-Leukemic Activity and Safety Data for gilteritinib in Relapsed/Refractory Acute Myeloid Leukemia
Jun 06, 2017
Exploratory Analysis of the Phase I/II CHRYSALIS Study of gilteritinib Demonstrates First Molecular Response to FLT3 Inhibitor in Acute Myeloid Leukemia
Jun 05, 2017
Astellas and Seattle Genetics Announce Updated Enfortumab Vedotin Phase 1 Data in Metastatic Urothelial Cancer at 2017 ASCO Annual Meeting